Skip to Content
A vastly improved search engine helps you find the latest on companies, business leaders, and news more easily.
Thermo Fisher Scientific, which sells equipment, software, and services for scientific research, had a stellar 2020, lifted by huge demand for its products, such as PCR tests, during the pandemic. The lab supplier collected $6.6 billion in revenue during the year from sales of instruments and other products to more than 200 customers trying to develop COVID-19 vaccines and treatments. Overall revenue rose 26% to $32 billion, compared with the prior year, while profits soared 73% to $6.4 billion. Even with the COVID vaccine rush behind them, the company is thinking big with its $17.4 billion acquisition of contract research business PPD, which it announced in April.
Lists ranking Thermo Fisher Scientific
Fortune 500 - 2022This year’s Fortune 500 marks the 68th running of ...READ MOREview in list
World’s Most Admired Companies - 2022Just as it dominates our economy, Big Tech now dom...READ MOREview in list
Global 500 - 2021Total revenue for the world’s biggest companies fe...READ MOREview in list